3420-63-1Relevant academic research and scientific papers
Design, synthesis, biological evaluation, and Structure - Activity relationships of substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates as new tubulin inhibitors mimicking combretastatin A-4
Fortin, Sébastien,Wei, Lianhu,Moreau, Emmanuel,Lacroix, Jacques,C?té, Marie-France,Petitclerc, éric,Kotra, Lakshmi P.,C.-Gaudreault, René
experimental part, p. 4559 - 4580 (2011/09/15)
Sixty-one phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates (PIB-SOs) and 13 of their tetrahydro-2-oxopyrimidin-1(2H)-yl analogues (PPB-SOs) were prepared and biologically evaluated. The antiproliferative activities of PIB-SOs on 16 cancer cell lines are
SUBSTITUTED 2-IMIDAZOLIDONES AND ANALOGS
-
Page/Page column 24-25; 84, (2011/09/19)
Compounds of formula (I): wherein R1, R2, R3, R4, R7, R6, R7, R8, R9, A, X and Y as defined herein are provided as useful for the treatment of cancer or for
Cyclic ureas as ortho directing substituents
Meigh,Alvarez,Joule
, p. 2012 - 2021 (2007/10/03)
Six-membered cyclic ureas are shown to have a weak ortho directing ability when linked through nitrogen to benzene and pyridine rings.
New substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives with α2-adrenoceptor antagonist activity
Mayer,Brunel,Chaplain,Piedecoq,Calmel,Schambel,Chopin,Wurch,Pauwels,Marien,Vidaluc,Imbert
, p. 3653 - 3664 (2007/10/03)
The emergence of a novel theory concerning the role of noradrenaline in the progression and the treatment of neurodegenerative diseases such as Parkinson's and Alzheimer's diseases has provided a new impetus toward the discovery of novel compounds acting at α2-adrenoceptors. A series of substituted 1-(2,3-dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl derivatives bearing an amide, urea, or imidazolidinone moiety was studied. Some members of this series of compounds proved to be potent α2-adrenoceptor antagonists with good selectivity versus α1-adrenergic and D2-dopamine receptors. Particular emphasis is given to compound 33g which displays potent α2-adrenoceptor binding affinity in vitro and central effects in vivo following oral administration.
